Comments: US HB4278 | 2021-2022 | 117th Congress
Bill Title: To direct the Comptroller General of the United States to conduct a study on how direct-to-consumer pharmaceutical advertising negatively impacts drug costs to consumers, and for other purposes.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced - Dead) 2021-07-01 - Referred to the Subcommittee on Health. [HB4278 Detail]
Text: Latest bill text (Introduced) [PDF]
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced - Dead) 2021-07-01 - Referred to the Subcommittee on Health. [HB4278 Detail]
Text: Latest bill text (Introduced) [PDF]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB4278 at this time. |